Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Systematic Review
  • Published:

Immune cell composition in unipolar depression: a comprehensive systematic review and meta-analysis

Abstract

Depression has been associated with inflammatory pathophysiological mechanisms, including alterations in amount of circulating immune cells. However, no meta-analysis within the past 20 years have reevaluated the circulating immune cells in blood and cerebrospinal fluid (CSF) from patients with depression compared to healthy controls. The aim of this study was to systematically evaluate the circulating immune cells in blood and CSF from patients with unipolar depression compared to healthy controls. Databases were searched up until February 12, 2021. Data-extraction was performed by two independent reviewers. 104 studies were included in the meta-analysis using fixed and random-effects models. Patients with depression had a significantly higher overall leukocyte count (35 studies; SMD, 0.46; 95% CI: 0.31–0.60, I2 = 68%), higher neutrophil count (24 studies; SMD, 0.52; 95% CI: 0.33–0.71, I2 = 77%) and higher monocyte count (27 studies; SMD, 0.32; 95% CI: 0.11–0.53, I2 = 77%) compared to healthy controls. Leukocyte counts were higher in inpatients, indicating a relation to depression severity. Furthermore, there were significant alterations in several lymphocyte subsets, including higher natural killer cells and T cell subsets. Higher neutrophil/lymphocyte ratio (11 studies; SMD = 0.24; 95% CI: 0.06–0.42, I2 = 73%), CD4/CD8 cell-ratio (26 studies; SMD = 0.14; 95% CI: 0.01–0.28, I2 = 42%) and T helper 17/T regulatory ratio (2 studies; SMD = 1.05; 95% CI: 0.15–1.95, I2 = 86%) were found in patients compared to healthy controls. CSF white cell count was higher in patients compared to controls (3 studies; SMD = 0.20; 95% CI: 0.01–0.38, I2 = 0%). There were no data for CSF cell subsets. This study suggests that there are several blood immune cell alterations in patients with unipolar depression compared to healthy controls, both in major leukocyte subsets and more specialized immune cell subsets.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: Graphical abstract of main findings.
Fig. 2: Blood leukocyte counts in patients with unipolar depression compared to healthy controls.
Fig. 3: Blood granulocyte counts in patients with unipolar depression compared to healthy controls.
Fig. 4: Blood monocyte counts in patients with unipolar depression compared to healthy controls.
Fig. 5: Blood natural killer cell counts and T cell subset counts in patients with unipolar depression compared to healthy controls.
Fig. 6: Blood immune cell ratios in patients with unipolar depression compared to healthy controls.

Similar content being viewed by others

References

  1. Spencer LJ, Abate D, Abate KH, Abay SM, Abbafati C, Abbasi N, et al. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392:1789–858.

  2. Rush AJ, Trivedi MH, Wisniewski SR, Nierenberg AA, Stewart JW, Warden D, et al. Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report. Am J Psychiatry. 2006;163:1905–17.

    Article  Google Scholar 

  3. Gronemann FH, Jorgensen MB, Nordentoft M, Andersen PK, Osler M. Incidence of, risk factors for, and changes over time in treatment-resistant depression in Denmark: a register-based cohort study. J Clin Psychiatry. 2018;79:17m11845.

  4. Reutfors J, Andersson TML, Brenner P, Brandt L, DiBernardo A, Li G, et al. Mortality in treatment-resistant unipolar depression: a register-based cohort study in Sweden. J Affect Disord. 2018;238:674–9.

    Article  Google Scholar 

  5. Benros ME, Waltoft BL, Nordentoft M, Ostergaard SD, Eaton WW, Krogh J, et al. Autoimmune diseases and severe infections as risk factors for mood disorders: a nationwide study. JAMA Psychiatry. 2013;70:812–20.

    Article  Google Scholar 

  6. Bonaccorso S, Marino V, Biondi M, Grimaldi F, Ippoliti F, Maes M. Depression induced by treatment with interferon-alpha in patients affected by hepatitis C virus. J Affect Disord. 2002;72:237–41.

    Article  CAS  Google Scholar 

  7. Köhler OE, Benros M, Nordentoft M, Farkouh ME, Iyengar RL, Mors O, et al. Effect of anti-inflammatory treatment on depression, depressive symptoms, and adverse effects a systematic review and meta-analysis of randomized clinical trials. JAMA Psychiatry. 2014;71:1381–91.

    Article  Google Scholar 

  8. Goldsmith DR, Rapaport MH, Miller BJ. A meta-analysis of blood cytokine network alterations in psychiatric patients: comparisons between schizophrenia, bipolar disorder and depression. Mol Psychiatry. 2016;21:1696–709.

    Article  CAS  Google Scholar 

  9. Mousten IV, Sørensen NV, Christensen RHB, Benros ME. Cerebrospinal fluid biomarkers in patients with unipolar depression compared with healthy control individuals: a systematic review and meta-analysis. JAMA Psychiatry. 2022. https://doi.org/10.1001/jamapsychiatry.2022.0645.

  10. Kohler CA, Freitas TH, Maes M, de Andrade NQ, Liu CS, Fernandes BS, et al. Peripheral cytokine and chemokine alterations in depression: a meta-analysis of 82 studies. Acta Psychiatr Scand. 2017;135:373–87.

    Article  CAS  Google Scholar 

  11. Mazza MG, Lucchi S, Tringali AGM, Rossetti A, Botti ER, Clerici M. Neutrophil/lymphocyte ratio and platelet/lymphocyte ratio in mood disorders: a meta-analysis. Prog Neuropsychopharmacol Biol Psychiatry. 2018;84:229–36.

    Article  Google Scholar 

  12. Herbert TB, Cohen S. Depression and immunity: a meta-analytic review. Psychol Bull. 1993;113:472–86.

    Article  CAS  Google Scholar 

  13. Zorrilla EP, Luborsky L, McKay JR, Rosenthal R, Houldin A, Tax A, et al. The relationship of depression and stressors to immunological assays: a meta-analytic review. Brain Behav Immun. 2001;15:199–226.

    Article  CAS  Google Scholar 

  14. Lynall M-E, Turner L, Bhatti J, Cavanagh J, de Boer P, Mondelli V, et al. Peripheral blood cell-stratified subgroups of inflamed depression. Biol Psychiatry. 2020;88:185–96.

    Article  CAS  Google Scholar 

  15. Hasselmann H, Gamradt S, Taenzer A, Nowacki J, Zain R, Patas K, et al. Pro-inflammatory monocyte phenotype and cell-specific steroid signaling alterations in unmedicated patients with major depressive disorder. Front Immunol. 2018;9:2693.

    Article  Google Scholar 

  16. Cai L, Xu L, Wei L, Chen W. Relationship of mean platelet volume to MDD: a retrospective study. Shanghai Arch Psychiatry. 2017;29:21–29.

    CAS  Google Scholar 

  17. Euteneuer F, Dannehl K, del Rey A, Engler H, Schedlowski M, Rief W. Peripheral immune alterations in major depression: the role of subtypes and pathogenetic characteristics. Front Psychiatry. 2017;8:250.

    Article  Google Scholar 

  18. Grosse L, Carvalho LA, Birkenhager TK, Hoogendijk WJ, Kushner SA, Drexhage HA, et al. Circulating cytotoxic T cells and natural killer cells as potential predictors for antidepressant response in melancholic depression. Restoration of T regulatory cell populations after antidepressant therapy. Psychopharmacology. 2016;;233:1679–88.

    Article  Google Scholar 

  19. Noor Suryani MA, Siti Nor Fairus MS, Che Maraina CH, Wong KK, Mohd Nazri S, Mohd Azhar MY. Major depressive disorder patients on antidepressant treatments display higher number of regulatory T cells. Malays J Pathol. 2019;41:169–76.

    Google Scholar 

  20. Patas K, Willing A, Demiralay C, Engler JB, Lupu A, Ramien C, et al. T cell phenotype and T cell receptor repertoire in patients with major depressive disorder. Front Immunol. 2018;9:291.

    Article  Google Scholar 

  21. Krause D, Stapf TM, Kirnich VB, Hennings A, Riemer S, Chrobok A, et al. Stability of cellular immune parameters over 12 weeks in patients with major depression or somatoform disorder and in healthy controls. Neuroimmunomodulation. 2018;25:7–17.

    Article  CAS  Google Scholar 

  22. Becking K, Haarman BCM, Grosse L, Nolen WA, Claes S, Arolt V, et al. The circulating levels of CD4+ t helper cells are higher in bipolar disorder as compared to major depressive disorder. J Neuroimmunol. 2018;319:28–36.

    Article  CAS  Google Scholar 

  23. Ahmetspahic D, Schwarte K, Ambrée O, Bürger C, Falcone V, Seiler K, et al. Altered B cell homeostasis in patients with major depressive disorder and normalization of CD5 surface expression on regulatory B cells in treatment responders. J Neuroimmune Pharm. 2018;13:90–99.

    Article  Google Scholar 

  24. Wells GA, Shea B, O’Connell D, Peterson J, Welch V, Losos M et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp. Accessed 2021.

  25. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177–88.

    Article  CAS  Google Scholar 

  26. Levine S, Rabinowitz J, Faries D, Lawson A, Ascher-Svanum H. Treatment response trajectories and antipsychotic medications: examination of up to 18 months of treatment in the CATIE chronic schizophrenia trial. Schizophr Res. 2012;137:141–6.

    Article  Google Scholar 

  27. Hedges LV. Distribution theory for Glass’s estimator of effect size and related estimators. J Educ Behav Stat. 1981;6:107–28.

    Article  Google Scholar 

  28. Hedges LV. Estimation of effect size from a series of independent experiments. Psychol Bull. 1982;92:490–9.

    Article  Google Scholar 

  29. Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al. Cochrane handbook for systematic reviews of interventions. 2nd ed. https://training.cochrane.org/: Cochrane Training; 2019.

  30. Egger M, Smith GD, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ Br Med J. 1997;315:629.

    Article  CAS  Google Scholar 

  31. Balduzzi S, Rücker G, Schwarzer G. How to perform a meta-analysis with R: a practical tutorial. Evid Based Ment Health. 2019;22:153–60.

    Article  Google Scholar 

  32. Bramer WM, Giustini D, de Jonge GB, Holland L, Bekhuis T. De-duplication of database search results for systematic reviews in EndNote. J Med Libr Assoc. 2016;104:240–3.

    Article  Google Scholar 

  33. Pavon L, Sandoval-Lopez G, Eugenia Hernandez M, Loria F, Estrada I, Perez M, et al. Th2 cytokine response in Major Depressive Disorder patients before treatment. J Neuroimmunol. 2006;172:156–65.

    Article  CAS  Google Scholar 

  34. Hattori K, Ota M, Sasayama D, Yoshida S, Matsumura R, Miyakawa T, et al. Increased cerebrospinal fluid fibrinogen in major depressive disorder. Sci Rep. 2015;5:11412.

    Article  CAS  Google Scholar 

  35. Lynch CJ, Gunning FM, Liston C. Causes and consequences of diagnostic heterogeneity in depression: paths to discovering novel biological depression subtypes. Biol Psychiatry. 2020;88:83–94.

    Article  CAS  Google Scholar 

  36. Köhler-Forsberg O, Buttenschøn HN, Tansey KE, Maier W, Hauser J, Dernovsek MZ, et al. Association between C-reactive protein (CRP) with depression symptom severity and specific depressive symptoms in major depression. Brain Behav Immun. 2017;62:344–50.

    Article  Google Scholar 

  37. Sørensen NV, Orlovska-Waast S, Jeppesen R, Klein-Petersen AW, Christensen RHB, Benros ME. Neuroinflammatory biomarkers in cerebrospinal fluid from 106 patients with recent-onset depression compared with 106 individually matched healthy control subjects. Biol Psychiatry. 2022. https://doi.org/10.1016/j.biopsych.2022.04.002.

  38. Cattane N, Vernon AC, Borsini A, Scassellati C, Endres D, Capuron L, et al. Preclinical animal models of mental illnesses to translate findings from the bench to the bedside: Molecular brain mechanisms and peripheral biomarkers associated to early life stress or immune challenges. Eur Neuropsychopharmacol J Eur Coll Neuropsychopharmacol. 2022;58:55–79.

    Article  CAS  Google Scholar 

  39. Bollen J, Trick L, Llewellyn D, Dickens C. The effects of acute inflammation on cognitive functioning and emotional processing in humans: a systematic review of experimental studies. J Psychosom Res. 2017;94:47–55.

    Article  Google Scholar 

  40. Baumeister D, Akhtar R, Ciufolini S, Pariante CM, Mondelli V. Childhood trauma and adulthood inflammation: a meta-analysis of peripheral C-reactive protein, interleukin-6 and tumour necrosis factor-α. Mol Psychiatry. 2016;21:642–9.

    Article  CAS  Google Scholar 

  41. Häfner S, Emeny RT, Lacruz ME, Baumert J, Herder C, Koenig W, et al. Association between social isolation and inflammatory markers in depressed and non-depressed individuals: results from the MONICA/KORA study. Brain Behav Immun. 2011;25:1701–7.

    Article  Google Scholar 

  42. Brown SJ, Huang X-F, Newell KA. The kynurenine pathway in major depression: what we know and where to next. Neurosci Biobehav Rev. 2021;127:917–27.

    Article  CAS  Google Scholar 

  43. Moncrieff J, Cooper RE, Stockmann T, Amendola S, Hengartner MP, Horowitz MA. The serotonin theory of depression: a systematic umbrella review of the evidence. Mol Psychiatry. 2022. https://doi.org/10.1038/s41380-022-01661-0. Online ahead of print.

  44. Costa-Ferro ZSM, do Prado-Lima PAS, Onsten GA, Oliveira GN, Brito GC, Ghilardi IM, et al. Bone marrow mononuclear cell transplant prevents rat depression and modulates inflammatory and neurogenic molecules. Prog Neuropsychopharmacol Biol Psychiatry. 2022;113:110455.

    Article  CAS  Google Scholar 

  45. Varatharaj A, Galea I. The blood-brain barrier in systemic inflammation. Brain Behav Immun. 2017;60:1–12.

    Article  CAS  Google Scholar 

  46. Eyre HA, Lavretsky H, Kartika J, Qassim A, Baune BT. Modulatory effects of antidepressant classes on the innate and adaptive immune system in depression. Pharmacopsychiatry. 2016;49:85–96.

    Article  CAS  Google Scholar 

  47. Bauer ME. Stress, glucocorticoids and ageing of the immune system. Stress. 2005;8:69–83.

    Article  CAS  Google Scholar 

  48. Johannsen NM, Priest EL, Dixit VD, Earnest CP, Blair SN, Church TS. Association of white blood cell subfraction concentration with fitness and fatness. Br J Sports Med. 2010;44:588–93.

    Article  CAS  Google Scholar 

  49. Mehta H, Nazzal K, Sadikot RT. Cigarette smoking and innate immunity. Inflamm Res J Eur Histamine Res Soc. 2008;57:497–503.

    CAS  Google Scholar 

Download references

Funding

This study was funded by grants from The Lundbeck Foundation (grant number R268–2016–3925 and R277–2018–1411). The funding agencies had no impact on the study design, data collection, data analysis, data interpretation, or writing of the report.

Author information

Authors and Affiliations

Authors

Contributions

MEB, SOW and BHF designed the study and systematic literature search. BHF conducted the screening of titles and abstracts. BHF and SOW did full text screening independently. BHF extracted all data. Data was validated by either NVS or SOW. TBB and NØ helped categorize immune cells. RHC made the statistical analysis plan and conducted the statistical analyses. All authors contributed to data interpretation. RHC, NVS and BHF conducted figures and tables. NVS drafted the manuscript including preparation of the supplementary. All authors contributed to the editing of the manuscript and all authors have read and accepted the final version of the manuscript.

Corresponding author

Correspondence to Michael Eriksen Benros.

Ethics declarations

Competing interests

The authors declare no competing interests.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sørensen, N.V., Frandsen, B.H., Orlovska-Waast, S. et al. Immune cell composition in unipolar depression: a comprehensive systematic review and meta-analysis. Mol Psychiatry 28, 391–401 (2023). https://doi.org/10.1038/s41380-022-01905-z

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41380-022-01905-z

This article is cited by

Search

Quick links